Sopharma ADSopharma AD - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This ESG score covers seventeen United Nations Sustainable Development Goals including: 'Zero Hunger', 'Responsible Production & Consumption' and 'Peace, Justice & Strong Institutions'. The webpage of Sopharma AD is assembled by All Street Sevva using cutting edge AI. Full Sustainability analysis of Sopharma AD can be reached by logging in.

Sopharma AD in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.0, social score of 5.3 and governance score of 4.6.

SDG Transparency Score for Sopharma AD 
Low
0 - 3

4.0

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Sopharma AD 
2.0

Environmental

5.3

Social

4.6

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1412Vallon Pharmaceuticals Inc
4.1
High
1412Vectura Group PLC
4.1
High
1443Sopharma AD
4.0
High
1443Adaptive Biotechnologies Corp
4.0
High
1443Ascletis Pharma Inc
4.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Sopharma AD have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Sopharma AD disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Sopharma AD report the average age of the workforce?

LockedSign up for free to unlock

Does Sopharma AD reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Sopharma AD disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Sopharma AD disclose cybersecurity risks?

LockedSign up for free to unlock

Does Sopharma AD offer flexible work?

LockedSign up for free to unlock

Does Sopharma AD have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Sopharma AD disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Sopharma AD conduct supply chain audits?

LockedSign up for free to unlock

Does Sopharma AD disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Sopharma AD conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Sopharma AD disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Sopharma AD disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Sopharma AD disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Sopharma AD disclose water use targets?

LockedSign up for free to unlock

Does Sopharma AD have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Sopharma AD have a product recall in the last two years?

LockedSign up for free to unlock

Does Sopharma AD disclose incidents of discrimination?

LockedSign up for free to unlock

Does Sopharma AD allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Sopharma AD issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Sopharma AD disclose parental leave metrics?

LockedSign up for free to unlock

Does Sopharma AD disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Sopharma AD disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Sopharma AD disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Sopharma AD support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Sopharma AD disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Sopharma AD reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Sopharma AD involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Sopharma AD disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Sopharma AD disclose its waste policy?

LockedSign up for free to unlock

Does Sopharma AD report according to TCFD requirements?

LockedSign up for free to unlock

Does Sopharma AD disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Sopharma AD disclose energy use targets?

LockedSign up for free to unlock

Does Sopharma AD disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Sopharma AD have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Sopharma AD
These potential risks are based on the size, segment and geographies of the company.

Sopharma AD researches and develops, produces, and trades in medicinal substances, finished drug forms, veterinary vaccines, infusion solutions, and plastic medical disposable products for human and veterinary medicine, and food supplements in Bulgaria and internationally. It offers products in various therapeutic areas, such as cardiology, gastroenterology, pain management, cough and cold, immunology and dermatology, respiratory and asthma, neurology and psychiatry, urology, and gynecology. The company's products comprise Carsil to treat gastroenterological disorders; Tempalgin, an analgesic; Tabex, a plant-based drug used for smoking secession; Tribestan, a plant-based drug used for stimulation of functions of the sexual system; Broncholytin, which is used to suppress cough; Analgin, a generic analgesic; Nivalin, a plant-based product used for diseases of the peripheral nervous system; and Methylprednisolon, a general medicine for cases of severe allergies and life-threatening conditions. It also trades in food supplements; provides secondary packaging services for pharmaceutical products and real estate leases; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; and purchases, collects, grows, produces, and trades in herbs and medicinal plants. In addition, the company engages in the retail trade of medicinal products and medical equipment; production of non-medicinal, and other products; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Further, it offers market and public opinion research services; and engages in non-pharma activities, such as veterinary vaccines, infusion solutions. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.

Sorry!

Failed to process!